Novartis’ $4 Million Gene Therapy — Real Price Or A Negotiation Ploy?

We are in a wondrous age of medicine where CURES for certain types of cancer, rare diseases, blindness and other scourges are imminent. We now need to figure out how to pay for them.

Read the full post on Forbes - Healthcare